172 related articles for article (PubMed ID: 10650816)
1. Expression of vascular endothelial growth factor in primary superficial bladder cancer.
Chow NH; Liu HS; Chan SH; Cheng HL; Tzai TS
Anticancer Res; 1999; 19(5C):4593-7. PubMed ID: 10650816
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
Crew JP; O'Brien T; Bradburn M; Fuggle S; Bicknell R; Cranston D; Harris AL
Cancer Res; 1997 Dec; 57(23):5281-5. PubMed ID: 9393750
[TBL] [Abstract][Full Text] [Related]
3. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates.
Crew JP; O'Brien T; Bicknell R; Fuggle S; Cranston D; Harris AL
J Urol; 1999 Mar; 161(3):799-804. PubMed ID: 10022687
[TBL] [Abstract][Full Text] [Related]
4. [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].
Guo ZH; Mei H; Huang J; Li SY
Ai Zheng; 2003 Mar; 22(3):307-9. PubMed ID: 12654193
[TBL] [Abstract][Full Text] [Related]
5. Different angiogenic pathways characterize superficial and invasive bladder cancer.
O'Brien T; Cranston D; Fuggle S; Bicknell R; Harris AL
Cancer Res; 1995 Feb; 55(3):510-3. PubMed ID: 7530595
[TBL] [Abstract][Full Text] [Related]
6. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting.
Borre M; Nerstrøm B; Overgaard J
Clin Cancer Res; 2000 May; 6(5):1882-90. PubMed ID: 10815911
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
8. Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression.
Crew JP; Fuggle S; Bicknell R; Cranston DW; de Benedetti A; Harris AL
Br J Cancer; 2000 Jan; 82(1):161-6. PubMed ID: 10638984
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
10. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer.
Xia G; Kumar SR; Hawes D; Cai J; Hassanieh L; Groshen S; Zhu S; Masood R; Quinn DI; Broek D; Stein JP; Gill PS
J Urol; 2006 Apr; 175(4):1245-52. PubMed ID: 16515971
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
Inoue K; Slaton JW; Karashima T; Yoshikawa C; Shuin T; Sweeney P; Millikan R; Dinney CP
Clin Cancer Res; 2000 Dec; 6(12):4866-73. PubMed ID: 11156246
[TBL] [Abstract][Full Text] [Related]
12. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.
Linderholm BK; Lindahl T; Holmberg L; Klaar S; Lennerstrand J; Henriksson R; Bergh J
Cancer Res; 2001 Mar; 61(5):2256-60. PubMed ID: 11280795
[TBL] [Abstract][Full Text] [Related]
13. Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer.
West AF; O'Donnell M; Charlton RG; Neal DE; Leung HY
Br J Cancer; 2001 Aug; 85(4):576-83. PubMed ID: 11506499
[TBL] [Abstract][Full Text] [Related]
14. [Expression of VEGF and tumor angiogenesis in bladder cancer].
Wang S; Xia T; Zhang Z; Kong X; Zeng L; Mi P; Xue Z
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):34-6. PubMed ID: 11831983
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus.
Shih CH; Ozawa S; Ando N; Ueda M; Kitajima M
Clin Cancer Res; 2000 Mar; 6(3):1161-8. PubMed ID: 10741747
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
Suzuki K; Morita T; Tokue A
Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between expression of vascular endothelial growth factor and prognosis of patients with esophageal squamous cell carcinoma].
Hu CZ; Wang YX; Zhang XZ
Ai Zheng; 2002 Mar; 21(3):301-4. PubMed ID: 12452000
[TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
20. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]